Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
Angiogenesis|March 5, 2013
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesisElena Porcù, Giampietro Viola, Roberta Bortolozzi, et al.
European Journal of Medicinal Chemistry|May 17, 2003
Recent developments in the field of A2A and A3 adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Andrea Bovero, et al.
Bioorganic & Medicinal Chemistry|December 30, 2011
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonistsPier Giovanni Baraldi, Giulia Saponaro, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|January 7, 2005
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key studyStefano Moro, Paolo Braiuca, Francesca Deflorian, et al.
Molecular Pharmacology|May 10, 2007
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 6, 2018
Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cellsRomeo Romagnoli, Filippo Prencipe, Luisa Carlota Lopez-Cara, et al.
Bioconjugate Chemistry|November 20, 2003
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptorsAlessandra Boschi, Licia Uccelli, Adriano Duatti, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2009
Synthesis and evaluation of a thio analogue of duocarmycin SAKaren S MacMillan, James P Lajiness, Carlota Lopez Cara, et al.
Current Pharmaceutical Design|October 9, 2002
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?Pier Giovanni Baraldi, Barbara Cacciari, Pier Andrea Borean, et al.
Bioorganic & Medicinal Chemistry|September 3, 2003
New strategies for the synthesis of A3 adenosine receptor antagonistsPier Giovanni Baraldi, Andrea Bovero, Francesca Fruttarolo, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Angiogenesis|March 5, 2013
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesisElena Porcù, Giampietro Viola, Roberta Bortolozzi, et al.
European Journal of Medicinal Chemistry|May 17, 2003
Recent developments in the field of A2A and A3 adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Andrea Bovero, et al.
Bioorganic & Medicinal Chemistry|December 30, 2011
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonistsPier Giovanni Baraldi, Giulia Saponaro, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|January 7, 2005
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key studyStefano Moro, Paolo Braiuca, Francesca Deflorian, et al.
Molecular Pharmacology|May 10, 2007
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 6, 2018
Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cellsRomeo Romagnoli, Filippo Prencipe, Luisa Carlota Lopez-Cara, et al.
Bioconjugate Chemistry|November 20, 2003
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptorsAlessandra Boschi, Licia Uccelli, Adriano Duatti, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2009
Synthesis and evaluation of a thio analogue of duocarmycin SAKaren S MacMillan, James P Lajiness, Carlota Lopez Cara, et al.
Current Pharmaceutical Design|October 9, 2002
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?Pier Giovanni Baraldi, Barbara Cacciari, Pier Andrea Borean, et al.
Bioorganic & Medicinal Chemistry|September 3, 2003
New strategies for the synthesis of A3 adenosine receptor antagonistsPier Giovanni Baraldi, Andrea Bovero, Francesca Fruttarolo, et al.
Pageof 16